Related references
Note: Only part of the references are listed.NK cells and ILCs in tumor immunotherapy
Simona Sivori et al.
MOLECULAR ASPECTS OF MEDICINE (2021)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer
Feng Yu et al.
TUMORI JOURNAL (2021)
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
May Daher et al.
CANCER DISCOVERY (2021)
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
Qijie Zhao et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
Kathrin Davari et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Increased interleukin-17A-producing gamma delta T cells predict favorable survival in elderly patients with LUAD and LUSC
Kele Cui et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
Nengzhi Pang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models
Yujing Xuan et al.
TRANSLATIONAL ONCOLOGY (2021)
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies
Chaoting Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
Ana L. Portillo et al.
ISCIENCE (2021)
Idecabtagene Vicleucel in Relapsed Myeloma
Keisuke Kidoguchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
Wenxiu Wang et al.
CANCER LETTERS (2020)
CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in Progress
Sarah A. Holstein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
CAR T and CAR NK cells in multiple myeloma: Expanding the targets
Urvi A. Shah et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Design and Characterization of an All-in-One Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
Katharina Zimmermann et al.
CANCERS (2020)
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice
Simona Porcellini et al.
FRONTIERS IN IMMUNOLOGY (2020)
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling
Benjamin Philipson et al.
SCIENCE SIGNALING (2020)
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
Afsheen Raza et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours
Mikiya Ishihara et al.
BMC CANCER (2020)
CAR-T design: Elements and their synergistic function
Jayapriya Jayaraman et al.
EBIOMEDICINE (2020)
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies
Manish Poojary et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson et al.
LANCET (2020)
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
Francesco Manfredi et al.
FRONTIERS IN IMMUNOLOGY (2020)
JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination
Heng Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Artificial T Cell Adaptor Molecule-Transduced TCR-T Cells Demonstrated Improved Proliferation Only When Transduced in a Higher Intensity
Toshiyasu Sakai et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1- Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
Lei Tao et al.
CANCERS (2020)
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
Meijia Yang et al.
THERANOSTICS (2020)
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
Jianxiang Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
Yingxi Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance
Smita S. Chandran et al.
IMMUNOLOGICAL REVIEWS (2019)
Target selection for CAR-T therapy
Jianshu Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Gene editing for immune cell therapies
Stefanie R. Bailey et al.
NATURE BIOTECHNOLOGY (2019)
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Ru Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Engineered T Cell Therapy for Cancer in the Clinic
Lijun Zhao et al.
FRONTIERS IN IMMUNOLOGY (2019)
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
Indu Ramachandran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
Xin GongSun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma
Edward A. Stadtmauer et al.
BLOOD ADVANCES (2019)
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva-Santos et al.
NATURE REVIEWS CANCER (2019)
T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies
Melinda A. Biernacki et al.
CANCER JOURNAL (2019)
T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Yu Ping et al.
PROTEIN & CELL (2018)
Surgical treatment of esophageal cancer in the era of multimodality management
Alicia S. Borggreve et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Esophageal cancer: Risk factors, genetic association, and treatment
Fang-Liang Huang et al.
ASIAN JOURNAL OF SURGERY (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs
Kotaro Miyao et al.
CANCER IMMUNOLOGY RESEARCH (2018)
EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
Hui Shi et al.
JOURNAL OF THORACIC DISEASE (2018)
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
Monica Casucci et al.
FRONTIERS IN IMMUNOLOGY (2018)
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
C. David Pauza et al.
FRONTIERS IN IMMUNOLOGY (2018)
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
Zhongzhen Yi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer4
Hazel Lote et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
TCR alpha beta/CD3 disruption enables CD3-specific antileukemic T cell immunotherapy
Jane Rasaiyaah et al.
JCI INSIGHT (2018)
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
Yong-Chen Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
Iulia Diaconu et al.
MOLECULAR THERAPY (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Natural killer cell-mediated immunosurveillance of human cancer
Karl-Johan Malmberg et al.
SEMINARS IN IMMUNOLOGY (2017)
Oesophageal cancer
Elizabeth C. Smyth et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma
Dennis C. Harrer et al.
BMC CANCER (2017)
Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma
Richard G. Everson et al.
NEURO-ONCOLOGY (2016)
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma
Nathan Singh et al.
ONCOIMMUNOLOGY (2016)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Avery D. Posey et al.
IMMUNITY (2016)
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
Shinichi Kageyama et al.
CLINICAL CANCER RESEARCH (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Adoptive cellular therapy: A race to the finish line
Carl H. June et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Richard A. Morgan et al.
JOURNAL OF IMMUNOTHERAPY (2013)
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice
Yoshitaka Shirakura et al.
CANCER SCIENCE (2012)
Share Paper
